Lessee, Operating Lease, Liability, to be Paid, Year One of SUPERNUS PHARMACEUTICALS, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: SUPERNUS PHARMACEUTICALS, INC. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
SUPERNUS PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 31 Dec 2025 was $12,413,000, a 51% increase year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$12,413,000	+$4,179,000	+51%	31 Dec 2025	10-K	02 Mar 2026	2025	FY
Q4 2024	$8,234,000			31 Dec 2024	10-K	25 Feb 2025	2024	FY
Q4 2022	$8,257,000	+$414,000	+5.3%	31 Dec 2022	10-K	09 Mar 2023	2022	FY
Q4 2021	$7,843,000	+$2,777,000	+55%	31 Dec 2021	10-K	13 Apr 2022	2021	FY
Q4 2020	$5,066,000	+$854,000	+20%	31 Dec 2020	10-K	08 Mar 2021	2020	FY
Q4 2019	$4,212,000			31 Dec 2019	10-K	28 Feb 2020	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.